Syneos Health Inc logo

Syneos Health Inc (SYNH)

Market Closed
27 Sep, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
42. 98
+0.01
+0.0233%
$
4.46B Market Cap
- P/E Ratio
- Div Yield
6.7M Volume
- Eps
$ 42.97
Previous Close
Add Transaction
Day Range
42.97 42.99
Year Range
22.89 52.23
Want to track SYNH and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

SYNH closed Wednesday higher at $42.98, an increase of 0.0233% from Tuesday's close, completing a monthly increase of 0% or $42.98. Over the past 12 months, SYNH stock gained 0%.
SYNH is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on one exchange.

SYNH Chart

People also search for

Ssr Mining Inc.
$ 25.57
-1.236%
Reynolds Consumer Products Inc.
$ 26.24
-0.9811%
UFP Industries, Inc.
$ 85.93
-3.3952%
Century Aluminum Company
$ 41.5
-2.5822%
Methanex Corporation
$ 54.81
+3.0651%

Syneos Health Inc (SYNH) FAQ

What is the stock price today?

The current price is $42.98.

On which exchange is it traded?

Syneos Health Inc is listed on NASDAQ (NGS).

What is its stock symbol?

The ticker symbol is SYNH.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 4.46B.

Has Syneos Health Inc ever had a stock split?

No, there has never been a stock split.

Syneos Health Inc Profile

Chemicals Industry
Materials Sector
Michelle Keefe CEO
NASDAQ (NGS) Exchange
87166B102 CUSIP
US Country
28,768 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Syneos Health, Inc. stands as a cornerstone in the biopharmaceutical industry, offering an integrated suite of solutions critical for advancing clinical development. This organization is instrumental in facilitating the pharmaceutical field's drive towards innovation by expediting the drug development process, thus enabling quicker access to new therapies. By fostering strategic partnerships and upholding a commitment to scientific excellence, Syneos Health plays an indispensable role in improving global health outcomes and reinforcing the biopharmaceutical supply chain. Through its full-spectrum services, the company significantly affects the development of novel treatments, simultaneously enhancing project efficiency and ensuring adherence to regulatory standards.

Products and Services

Syneos Health, Inc. provides a diverse array of services aimed at supporting the pharmaceutical industry at various stages of the drug development pipeline. Each service is designed to streamline the process, making innovations more accessible and efficient.

  • Clinical Development Services: Offering comprehensive management services for clinical trials, Syneos Health ensures that studies are conducted efficiently, meeting all regulatory requirements. This includes patient recruitment, trial monitoring, and data management, essential for the successful development of new therapies.
  • Commercialization Advisory: Syneos Health provides expert advisory services to help pharmaceutical companies navigate the complex process of bringing a new drug to market. This encompasses market analysis, branding strategies, and launch planning to ensure the successful commercialization of innovative therapies.
  • Biopharmaceutical Consulting Services: With specialized consulting services, the company assists in strategic decision-making throughout the drug development lifecycle. From early-stage discovery through to market entry and beyond, Syneos Health offers insights and expertise that help in optimizing the path to product approval and ensuring market success.

Contact Information

Address: 1030 Sync Street
Phone: 919 876 9300